4-methylthioamphetamine has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies
Studies (4-methylthioamphetamine) | Trials (4-methylthioamphetamine) | Recent Studies (post-2010) (4-methylthioamphetamine) | Studies (1-(3-chlorophenyl)piperazine) | Trials (1-(3-chlorophenyl)piperazine) | Recent Studies (post-2010) (1-(3-chlorophenyl)piperazine) |
---|---|---|---|---|---|
38 | 0 | 9 | 833 | 142 | 87 |
Protein | Taxonomy | 4-methylthioamphetamine (IC50) | 1-(3-chlorophenyl)piperazine (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceglia, I; Gobbi, M; Mennini, T; Moia, M; Pirona, L; Reyes-Parada, M; Scorza, C | 1 |
1 other study(ies) available for 4-methylthioamphetamine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Topics: Amphetamines; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Tritium | 2002 |